Regeneron joins the hunt for antibodies to fight a brewing pandemic as researchers whip up new trials for antivirals
Count Regeneron as the latest big biopharma company to pitch in on finding a therapy to combat the Wuhan virus.
Health and Human Services said on Tuesday that they’ll be working with Regeneron to use its antibody platform tech — one of the best in the world — to hunt for a therapy to fight the lethal virus. This is an expansion of a joint project they set up a little more than 2 years ago to hunt for antibodies that worked against Ebola and 9 other viruses, including flu viruses.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.